<DOC>
	<DOCNO>NCT00181870</DOCNO>
	<brief_summary>This open-label pilot study 1200 mg/day carbamazepine ER ( Equetro ) treatment child meet DSM-IV criterion Bipolar I , Bipolar II , Bipolar Spectrum Disorder . The main goal study begin address void information safety , tolerability effectiveness Equetro treatment Pediatric Bipolar Disorder .</brief_summary>
	<brief_title>Equetro Treatment Mania Children Ages 6-12 With Bipolar Disorder</brief_title>
	<detailed_description>Initial clinical evidence suggest carbamazepine ( CBZ ) may play therapeutic role management pediatric bipolar disorder . A recent study find nearly 50 % patient take immediate-release CBZ side effect 20 % patient side-effects switch extended release ( ER ) version drug , despite high dos . In addition , ER formulation CBZ potential decrease peak-related side effect improve efficacy high blood level . Thus , ER formulation CBZ may improve effectiveness adherence treatment . The goal pilot study evaluate safety effectiveness Equetro treatment bipolar I , bipolar II , bipolar spectrum disorder child age 6-12 course 8-weeks . We propose exploratory study sufficient safety , tolerability , effectiveness Equetro treatment Pediatric Bipolar Disorder . The result study used generate hypothesis large randomize control clinical trial explicit hypotheses sufficient statistical power .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>1 . Male female subject , 612 year age . 2 . Subjects must DSMIV diagnosis bipolar I , bipolar II disorder bipolar spectrum disorder currently display manic , hypomanic , mixed symptom ( without psychotic feature ) accord DSMIV base clinical assessment structure diagnostic interview ( Kidd Schedule Affective Disorders Schizophrenia Epidemiological Version ) ( Kaufman , Birmaher et al . 1997 ) . Bipolar Spectrum Disorder ( subthreshold bipolar disorder ) operationalized severe mood disturbance , meet DSMIV Criteria A bipolar disorder meet few element criterion B ( require 2 item elation category 3 irritability ) . 3 . Subjects legal representative must level understanding sufficient communicate intelligently investigator study coordinator , cooperate test examination require protocol . 4 . Subjects legal representative must consider reliable . 5 . Each subject his/her authorized legal representative must understand nature study . The subject 's authorized legal representative must sign informed consent document subject must sign informed assent document . 6 . Subjects must initial score YMRS total score least 20 . 7 . Subject must able participate mandatory blood draw . 8 . Subject must able swallow pill . 9 . Subjects comorbid ADHD , ODD , CD , anxiety depressive disorder allow participate study provide meet exclusionary criterion . 10 . For concomitant therapy use treat ADHD , subject must stable dose medication 1 month prior study enrollment . The dose ADHD therapy change throughout duration study . Strattera allow . 1 . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild . 2 . Serious , unstable illness include hepatic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . 3 . Uncorrected hypothyroidism hyperthyroidism . 4 . History sensitivity carbamazepine know sensitivity tricyclic compound amitriptyline , desipramine , imipramine , protriptyline nortriptyline . Severe allergy multiple adverse drug reaction . 5 . Nonfebrile seizure without clear resolve etiology . 6 . History previous bone marrow depression 7 . DSMIV substance ( except nicotine caffeine ) dependence within past 6 month . 8 . Judged clinically serious suicidal risk . 9 . Any concomitant medication primarily central nervous system activity specify Concomitant Medication portion protocol . 10 . A nonresponder history intolerance carbamazepine adequate trial ( 2 month adequate dose ) determine clinician . 11 . Current diagnosis schizophrenia . 12 . Pregnant nursing female .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>child</keyword>
	<keyword>mania</keyword>
	<keyword>Equetro</keyword>
</DOC>